<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38226810</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Pathogenicity and landscape of differential gene expression in mice orally infected with clinical coxsackievirus A6 (CA6).</ArticleTitle><Pagination><StartPage>e0135823</StartPage><MedlinePgn>e0135823</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01358-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01358-23</ELocationID><Abstract><AbstractText>Hand, foot, and mouth disease (HFMD) is caused by more than 20 pathogenic enteroviruses belonging to the Picornaviridae family and <i>Enterovirus</i> genus. Since the introduction of the enterovirus-71 (EV71) vaccine in 2016, the number of HFMD cases caused by EV71 has decreased. However, cases of infections caused by other enteroviruses, such as coxsackievirus A6 (CA6) and coxsackievirus A10, have been increasing accordingly. In this study, we used a clinical isolate of CA6 to establish an intragastric infection mouse model using 7-day-old mice to mimic the natural transmission route, by which we investigated the differential gene expression profiles associated with virus infection and pathogenicity. After intragastric infection, mice exhibited hind limb paralysis symptoms and weight loss, similar to those reported for EV71 infection in mice. The skeletal muscle was identified as the main site of virus replication, with a peak viral load reaching 2.31 × 10<sup>7</sup> copies/mg at 5 dpi and increased infiltration of inflammatory cells. RNA sequencing analysis identified differentially expressed genes (DEGs) after CA6 infection. DEGs in the blood, muscle, brain, spleen, and thymus were predominantly enriched in immune system responses, including pathways such as Toll-like receptor signaling and PI3K-Akt signaling. Our study has unveiled the genes involved in the host immune response during CA6 infection, thereby enhancing our comprehension of the pathological mechanism of HFMD.IMPORTANCEThis study holds great significance for the field of hand, foot, and mouth disease (HFMD). It not only delves into the disease's etiology, transmission pathways, and severe complications but also establishes a novel mouse model that mimics the natural coxsackievirus A6 infection process, providing a pivotal platform to delve deeper into virus replication and pathogenic mechanisms. Additionally, utilizing RNA-seq technology, it unveils the dynamic gene expression changes during infection, offering valuable leads for identifying novel therapeutic drug targets. This research has the potential to enhance our understanding of HFMD, offering fresh perspectives for disease prevention and treatment and positively impacting children's health worldwide.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6831-360X</Identifier><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Wanjun</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-8395-324X</Identifier><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Gengxin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hekai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Xiaoyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Servicebio, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Binbin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0214-2224</Identifier><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiangning</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1264-6664</Identifier><AffiliationInfo><Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Human Disease Comparative Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center of Technology Innovation for Animal Models, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022YFC2303404</GrantID><Agency>MOST | National Key Research and Development Program of China (NKPs)</Agency><Country /></Grant><Grant><GrantID>2022-I2M-1-020, 2021-1-I2 M-035</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-seq</Keyword><Keyword MajorTopicYN="N">coxsackievirus A6 (CA6)</Keyword><Keyword MajorTopicYN="N">hand, foot, and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">mouse model</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38226810</ArticleId><ArticleId IdType="pmc">PMC10878243</ArticleId><ArticleId IdType="doi">10.1128/jvi.01358-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu B, Zhong J, Xia H, Gong S, Xiao M, Xie J, Zhang Y, Hua L, Lian G. 2010. Etiology of hand, foot and mouth disease in Guangzhou in 2008. Zhonghua Er Ke Za Zhi= Chinese Journal of Pediatrics 48:127–130.</Citation><ArticleIdList><ArticleId IdType="pubmed">20426938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu WS, Kang B, Hong J, Hwang S, Kim A, Kim J, Cheon D-S. 2010. Enterovirus 71 infection with central nervous system involvement, South Korea. Emerg Infect Dis 16:1764–1766. doi:10.3201/eid1611.100104</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1611.100104</ArticleId><ArticleId IdType="pmc">PMC3294506</ArticleId><ArticleId IdType="pubmed">21029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B, Levent F. 2018. Hand, foot, and mouth disease. JAMA 320:2492. doi:10.1001/jama.2018.17288</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.17288</ArticleId><ArticleId IdType="pubmed">30561482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Feng Z, Yang Y, Self S, Gao Y, Longini IM, Wakefield J, Zhang J, Wang L, Chen X, et al. . 2011. Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology 22:781–792. doi:10.1097/EDE.0b013e318231d67a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e318231d67a</ArticleId><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D. 2016. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol 205:397–407. doi:10.1007/s00430-016-0465-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, Hanaoka N, Okabe N, Yoshida H, Yasui Y, Kobayashi M, et al. . 2012. Hand, foot, and mouth disease caused by coxsackievirus A6. Emerg Infect Dis 18:337–339. doi:10.3201/eid1802.111147</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1802.111147</ArticleId><ArticleId IdType="pmc">PMC3310456</ArticleId><ArticleId IdType="pubmed">22304983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. 2015. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther 13:1061–1071. doi:10.1586/14787210.2015.1058156</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiaoling ZYH. 2016. Research progress on hand, foot and mouth disease caused by coxsackievirus A6. Med Rec 2016:3953–3956.</Citation></Reference><Reference><Citation>Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen M-L, Vuorinen T, Roivainen M. 2010. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol 48:49–54. doi:10.1016/j.jcv.2010.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.02.002</ArticleId><ArticleId IdType="pubmed">20189452</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterback R, Vuorinen T, Linna M, Susi P, Hyypiä T, Waris M. 2009. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis 15:1485–1488. doi:10.3201/eid1509.090438</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1509.090438</ArticleId><ArticleId IdType="pmc">PMC2819858</ArticleId><ArticleId IdType="pubmed">19788821</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, Henquell C, Archimbaud C, Ughetto S, Antona D, Bailly J-L, Peigue-Lafeuille H. 2012. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect 18:E110–E118. doi:10.1111/j.1469-0691.2012.03789.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03789.x</ArticleId><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei S-H, Huang Y-P, Liu M-C, Tsou T-P, Lin H-C, Lin T-L, Tsai C-Y, Chao Y-N, Chang L-Y, Hsu C-M. 2011. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis 11:346. doi:10.1186/1471-2334-11-346</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-11-346</ArticleId><ArticleId IdType="pmc">PMC3297538</ArticleId><ArticleId IdType="pubmed">22168544</ArticleId></ArticleIdList></Reference><Reference><Citation>Flett K, Youngster I, Huang J, McAdam A, Sandora TJ, Rennick M, Smole S, Rogers SL, Nix WA, Oberste MS, Gellis S, Ahmed AA. 2012. Hand, foot, and mouth disease caused by coxsackievirus A6. Emerg Infect Dis 18:1702–1704. doi:10.3201/eid1810.120813</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1810.120813</ArticleId><ArticleId IdType="pmc">PMC3471644</ArticleId><ArticleId IdType="pubmed">23017893</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease, C. and Prevention . 2012. Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 — Alabama, Connecticut, California, and Nevada, November 2011–February 2012. MMWR Morb Mortal Wkly Rep 61:213–214.</Citation><ArticleIdList><ArticleId IdType="pubmed">22456122</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimbao J, Rodrigo P, Alberto MJ, Omeñaca M. 2010. Onychomadesis outbreak linked to hand, foot, and mouth disease. Euro Surveill 15:37. doi:10.2807/ese.15.37.19663-en</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.15.37.19663-en</ArticleId><ArticleId IdType="pubmed">20929644</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W-C, Huang L-M, Lu C-Y, Cheng A-L, Chang L-Y. 2013. Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study. Virol J 10:209. doi:10.1186/1743-422X-10-209</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-209</ArticleId><ArticleId IdType="pmc">PMC3717056</ArticleId><ArticleId IdType="pubmed">23800163</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao CD, Yergolkar P, Shankarappa KS. 2012. Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007-2009. Emerg Infect Dis 18:1833–1840. doi:10.3201/eid1811.111457</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1811.111457</ArticleId><ArticleId IdType="pmc">PMC3559176</ArticleId><ArticleId IdType="pubmed">23092622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Cao Z, Zeng DD, Wang Q, Wang X, Qian H. 2014. Epidemiological analysis, detection, and comparison of space-time patterns of Beijing hand-foot-mouth disease (2008-2012). PLoS ONE 9:e92745. doi:10.1371/journal.pone.0092745</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092745</ArticleId><ArticleId IdType="pmc">PMC3963949</ArticleId><ArticleId IdType="pubmed">24663329</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Mao Q, Li S, Gao F, Zhao H, Liu Y, Wan J, Ye X, Xia N, Cheng T, Liang Z. 2016. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6. Antiviral Res 134:50–57. doi:10.1016/j.antiviral.2016.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.08.025</ArticleId><ArticleId IdType="pubmed">27582066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Dong Z, Wei Q, Carr MJ, Li J, Ding S, Tong Y, Li D, Shi W. 2017. A neonatal murine model of coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy. J Virol 91. doi:10.1128/JVI.02450-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02450-16</ArticleId><ArticleId IdType="pmc">PMC5391469</ArticleId><ArticleId IdType="pubmed">28250116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Zhang Y, Lin H, Cheng Q, Lu X, Liu W, Zhou R, Zhong B, Tian X. 2021. A 10-day-old murine model of coxsackievirus A6 infection for the evaluation of vaccines and antiviral drugs. Front Immunol 12:665197. doi:10.3389/fimmu.2021.665197</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665197</ArticleId><ArticleId IdType="pmc">PMC8155526</ArticleId><ArticleId IdType="pubmed">34054834</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Sun T, Tao L, Ji W, Zhu P, Liang R, Zhang Y, Chen S, Yang H, Jin Y, et al. . 2022. A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model. Emerg Microbes Infect 11:2248–2263. doi:10.1080/22221751.2022.2119166</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2119166</ArticleId><ArticleId IdType="pmc">PMC9518251</ArticleId><ArticleId IdType="pubmed">36036059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S-Y, Ko M-K, Lee K-N, Choi J-H, You S-H, Pyo H-M, Lee M-H, Kim B, Lee J-S, Park J-H. 2016. Application of mouse model for effective evaluation of foot-and-mouth disease vaccine. Vaccine 34:3731–3737. doi:10.1016/j.vaccine.2016.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.06.008</ArticleId><ArticleId IdType="pubmed">27340094</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. 2012. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 86:11967–11976. doi:10.1128/JVI.00902-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-12</ArticleId><ArticleId IdType="pmc">PMC3486452</ArticleId><ArticleId IdType="pubmed">22951825</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JKW, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol 86:2121–2131. doi:10.1128/JVI.06103-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Lei H-Y, Liu C-C. 2012. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol 2012:876241. doi:10.1155/2012/876241</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/876241</ArticleId><ArticleId IdType="pmc">PMC3432373</ArticleId><ArticleId IdType="pubmed">22956971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y-S, Yang Z-N, Xu F, Chen C, Lu H-J, Jiang J-M, Zhang Y-J, Zhu H-P, Yao P-P. 2019. Global gene expression analysis of the brainstem in EV71- and CVA16-infected gerbils. Viruses 12. doi:10.3390/v12010046</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010046</ArticleId><ArticleId IdType="pmc">PMC7019476</ArticleId><ArticleId IdType="pubmed">31906004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T, Li D, Dai X, Meng C, Li Y, Cheng C, Ji W, Zhu P, Chen S, Yang H, et al. . 2023. Local immune dysregulation and subsequent inflammatory response contribute to pulmonary edema caused by Enterovirus infection in mice. J Med Virol 95:e28454. doi:10.1002/jmv.28454</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28454</ArticleId><ArticleId IdType="pubmed">36597906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, Pescarmona R, Talouarn E, Rinchai D, Zhang P, et al. . 2023. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science 379:eabo3627. doi:10.1126/science.abo3627</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo3627</ArticleId><ArticleId IdType="pmc">PMC10451000</ArticleId><ArticleId IdType="pubmed">36538032</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot-Cooper C, Pantelejevs T, Shannon JP, Cherry CR, Au MT, Hyvönen M, Hickman HD, Smith GL. 2022. Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling. Cell Host Microbe 30:357–372. doi:10.1016/j.chom.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8912257</ArticleId><ArticleId IdType="pubmed">35182467</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L-Y, Huang H-H, Zhen C, Chen S-Y, Song B, Cao W-J, Shen L-L, Zhou M-J, Zhang X-C, Xu R, et al. . 2023. Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection. Emerg Microbes Infect 12:2150566. doi:10.1080/22221751.2022.2150566</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2150566</ArticleId><ArticleId IdType="pmc">PMC9769146</ArticleId><ArticleId IdType="pubmed">36408648</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv C, Zhang Q, Zhao L, Yang J, Zou Z, Zhao Y, Li C, Sun X, Lin X, Jin M. 2022. African swine fever virus infection activates inflammatory responses through downregulation of the anti-inflammatory molecule C1QTNF3. Front Immunol 13:1002616. doi:10.3389/fimmu.2022.1002616</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1002616</ArticleId><ArticleId IdType="pmc">PMC9598424</ArticleId><ArticleId IdType="pubmed">36311798</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Wang H, Li Z, Li F, Liang L, Zou Y, Shen H, Li J, Xia Y, Cheng Z, et al. . 2022. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol 76:135–147. doi:10.1016/j.jhep.2021.08.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.08.027</ArticleId><ArticleId IdType="pubmed">34509526</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard D, Huang W, Izadmehr S, O’Connor CM, Wiredja DD, Wang Z, Zaware N, Chen Y, Schlatzer DM, Kiselar J, et al. . 2020. Selective PP2A enhancement through biased heterotrimer stabilization. Cell 181:688–701. doi:10.1016/j.cell.2020.03.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.038</ArticleId><ArticleId IdType="pmc">PMC7243596</ArticleId><ArticleId IdType="pubmed">32315618</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Huseinovic A, Jaspers A, Yuan L, Steenbergen RDM. 2023. Downregulation of miR-193a/b-3p during HPV-induced cervical carcinogenesis contributes to anchorage-independent growth through PI3K–AKT pathway regulators. J Med Virol 95:e28589. doi:10.1002/jmv.28589</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28589</ArticleId><ArticleId IdType="pubmed">36799263</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Komatsu M. 2011. Autophagy: renovation of cells and tissues. Cell 147:728–741. doi:10.1016/j.cell.2011.10.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.026</ArticleId><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui G, Wang H, Yang C, Zhou X, Wang J, Wang T, Ma T. 2022. Berberine prevents lethal EV71 neurological infection in newborn mice. Front Pharmacol 13:1027566. doi:10.3389/fphar.2022.1027566</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1027566</ArticleId><ArticleId IdType="pmc">PMC9640474</ArticleId><ArticleId IdType="pubmed">36386168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VTK. 2010. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 14:e1076–e1081. doi:10.1016/j.ijid.2010.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>